BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6728910)

  • 1. The effect of fluperlapine in acute psychotic patients.
    Dieterle D; Eben E; Einhäupl K; Hippius H; Klein H; Rüther E; Schmauss M
    Pharmacopsychiatry; 1984 Mar; 17(2):57-60. PubMed ID: 6728910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
    Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
    Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risperidone in the early treatment of first-episode psychosis: a two-year follow-up study].
    Gutiérrez Fraile M; Segarra Echevarría R; González-Pinto Arrillaga A; Martínez Junquera G
    Actas Esp Psiquiatr; 2002; 30(3):142-52. PubMed ID: 12106515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short survey on untoward effects of fluperlapine.
    Müller-Oerlinghausen B
    Arzneimittelforschung; 1984; 34(1A):131-4. PubMed ID: 6145429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a multicenter AMDP study with fluperlapine in schizophrenic patients.
    Woggon B; Heinrich K; Küfferle B; Müller-Oerlinghausen B; Pöldinger W; Rüther E; Schied HW
    Arzneimittelforschung; 1984; 34(1A):122-4. PubMed ID: 6145427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary note on the antipsychotic efficacy of bromperidol.
    Bataille M
    Acta Psychiatr Belg; 1978; 78(1):173-9. PubMed ID: 347879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)].
    Ackenheil M; Bräu H; Burkhart A; Franke A; Pacha W
    Arzneimittelforschung; 1976; 26(6):1156-8. PubMed ID: 989406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaco-EEG studies with fluperlapine.
    Matejcek M; Neff G; Tjeerdsma H; Krebs E
    Arzneimittelforschung; 1984; 34(1A):114-20. PubMed ID: 6145426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia.
    McElroy SL; Dessain EC; Pope HG; Cole JO; Keck PE; Frankenberg FR; Aizley HG; O'Brien S
    J Clin Psychiatry; 1991 Oct; 52(10):411-4. PubMed ID: 1938976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between prolactin response and clinical efficacy of risperidone in acute psychotic inpatients.
    Lee BH; Kim YK
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):658-62. PubMed ID: 16466670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coadministration of clozapine and fluvoxamine in psychotic patients--clinical experience.
    Lammers CH; Deuschle M; Weigmann H; Härtter S; Hiemke C; Heese C; Heuser I
    Pharmacopsychiatry; 1999 Mar; 32(2):76-7. PubMed ID: 10333167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study.
    Løwert AC; Rasmussen EM; Holm R; Almbjerg F; Calberg H; Joensen A; Nimb M; Baden H; Andersen E; Westergård T
    Pharmatherapeutica; 1989; 5(6):380-6. PubMed ID: 2687895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin level during 5 years of risperidone treatment in patients with psychotic disorders.
    Eberhard J; Lindström E; Holstad M; Levander S
    Acta Psychiatr Scand; 2007 Apr; 115(4):268-76. PubMed ID: 17355517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the adverse reactions and efficacy of long-term treatment with flupirtine: preliminary results of an ongoing twelve-month study with 200 patients suffering from chronic pain states in arthrosis or arthritis.
    Herrmann WM; Kern U; Aigner M
    Postgrad Med J; 1987; 63 Suppl 3():87-103. PubMed ID: 2451818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of long-acting risperidone in elderly psychotic patients.
    Kissling W; Glue P; Medori R; Simpson S
    Hum Psychopharmacol; 2007 Dec; 22(8):505-13. PubMed ID: 17902187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flupenthixol versus haloperidol in acute psychosis.
    Parent M; Toussaint C
    Pharmatherapeutica; 1983; 3(5):354-64. PubMed ID: 6844372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluperlapine in 104 schizophrenic patients. Open multicenter trial.
    Fischer-Cornelssen KA
    Arzneimittelforschung; 1984; 34(1A):125-30. PubMed ID: 6145428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.